Beyond IkappaBs: alternative regulation of NF-kappaB activity
- PMID: 17431096
- DOI: 10.1096/fj.06-7615rev
Beyond IkappaBs: alternative regulation of NF-kappaB activity
Abstract
The transcription factor nuclear factor-kappa B (NF-kappaB) is a crucial regulator of many physiological and patho-physiological processes, including control of the adaptive and innate immune responses, inflammation, proliferation, tumorigenesis, and apoptosis. Thus, the tight regulation of NF-kappaB activity within a cell is extremely important. The central mechanism of NF-kappaB regulation is the signal-induced proteolytic degradation of a family of cytoplasmic inhibitors of NF-kappaB, the IkappaBs. However, with the discovery of an IkappaB-independent noncanonical or "alternative" pathway of NF-kappaB activation, the importance of other regulatory mechanisms responsible for the fine-tuning of NF-kappaB became clear. Post-translational modification, especially phosphorylation, of the Rel proteins, of which dimeric NF-kappaB is composed, are such alternative regulatory mechanisms. The best analyzed example is RelA phosphorylation, which takes place at specific amino acids resulting in distinct functional changes of this gene regulatory protein. The interaction of NF-kappaB with other proteins such as glucocorticoid receptors is very important for the regulation of NF-kappaB activity. Recently, exciting new concepts of IkappaB-independent NF-kappaB control like dimer exchange and nucleolar sequestration of RelA have been described, indicating that many aspects of NF-kappaB control are waiting to be discovered.
Similar articles
-
[NF-kappaB tumorigenesis and drug developement].Sheng Wu Gong Cheng Xue Bao. 2005 Jan;21(1):12-8. Sheng Wu Gong Cheng Xue Bao. 2005. PMID: 15859322 Review. Chinese.
-
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.Annu Rev Immunol. 2000;18:621-63. doi: 10.1146/annurev.immunol.18.1.621. Annu Rev Immunol. 2000. PMID: 10837071 Review.
-
Regulation and function of IKK and IKK-related kinases.Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review.
-
Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.Trends Biochem Sci. 2005 Jan;30(1):43-52. doi: 10.1016/j.tibs.2004.11.009. Trends Biochem Sci. 2005. PMID: 15653325 Review.
-
Multiple redox regulation in NF-kappaB transcription factor activation.Biol Chem. 1997 Nov;378(11):1237-45. Biol Chem. 1997. PMID: 9426183 Review.
Cited by
-
Examination of Novel Immunomodulatory Effects of L-Sulforaphane.Nutrients. 2021 Feb 12;13(2):602. doi: 10.3390/nu13020602. Nutrients. 2021. PMID: 33673203 Free PMC article.
-
PPM1A is a RelA phosphatase with tumor suppressor-like activity.Oncogene. 2014 May 29;33(22):2918-27. doi: 10.1038/onc.2013.246. Epub 2013 Jul 1. Oncogene. 2014. PMID: 23812431 Free PMC article.
-
NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells.Cancers (Basel). 2010 Nov 5;2(4):1838-60. doi: 10.3390/cancers2041838. Cancers (Basel). 2010. PMID: 24281204 Free PMC article.
-
Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells.Clin Cancer Res. 2008 Dec 15;14(24):8143-51. doi: 10.1158/1078-0432.CCR-08-1539. Clin Cancer Res. 2008. PMID: 19088029 Free PMC article.
-
Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk.Nat Immunol. 2009 Feb;10(2):203-13. doi: 10.1038/ni.1692. Epub 2009 Jan 4. Nat Immunol. 2009. PMID: 19122653
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources